Search for:
Search for:
Healthcare Professionals
Publications
Contact
News
Español
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Supporter Program
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News
Computer Program
The MS Focus Computer Program provides laptop or desktop computers for individuals with MS on...
/Get-Help/MSF-Programs-Grants/Computer-Program
Shop
Privacy
Terms of Use
Site Map
Brain neuron density may be better disease progression indicator
May 12, 2017
A new study suggests demyelination may not be as good an indicator of disease progression in multiple sclerosis as previously thought. The authors said trying to detect demyelinating lesions in the cortex may be less important than measuring the density of neurons in the brain and starting early active treatment.
Researchers from Queen Mary University of London dissected and analyzed brains from nine people with MS and seven healthy controls. They found that the number of neurons was 14.9 billion in MS versus 24.4 billion in controls – a 39 percent difference. The density of neurons in MS was smaller by 28 percent, and cortical volume by 26 percent, and they found that the whole brain was affected equally.
Importantly, the number of neurons was strongly linked with the thickness of the cortex, which can be measured by MRI. The decline in volume of the cortex could therefore be detected in vivo and be used to predict neuronal loss in patients or measure neurodegeneration during clinical trials.
Because the loss of neurons is responsible for cognitive and other functions, which occurs early in MS, the researchers said early treatment is key to avoiding neurodegeneration.
The findings were published in the journal
Neuropathology and Applied Neurobiology
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more